AGOMAB THERAPEUTICS NV
Q2 2026 13F Holders
Symbol
AGMB
CUSIP
00860C102
Type
Equity
Class
SPONSORED ADS
Num filings
35
Total reported value, excl. options
$357 M
Compare 2026 Q2 to
2026 Q3
2026 Q1
Manager
Report Date
Value ($000)
Shares
Option Type